Testing a new medication for liver disease in healthy volunteers

This is an early-stage safety trial testing HEC169584, a new experimental medication being developed to treat non-alcoholic fatty liver disease. Researchers will give healthy volunteers gradually increasing doses of the medication to see how well it is tolerated, how the body processes it, and whether food affects how it works.

Before this medication can be tested in patients who actually have liver disease, researchers need to understand how safe it is, what side effects it might cause, and how the body handles it in healthy people first.